role hepatic lipids hepatic insulin resistance type diabetes
non-alcoholic fatty liver disease downstream sequelae hepatic insulin resistance type diabetes rapidly growing epidemics lead increased morbidity mortality rates soaring health-care costs developing interventions requires comprehensive understanding mechanisms excess hepatic lipid develops causes hepatic insulin resistance type diabetes proposed mechanisms implicate various lipid species inflammatory signalling cellular modifications studies mice humans elucidated key role hepatic diacylglycerol activation protein kinase c epsilon triggering hepatic insulin resistance therapeutic approaches based mechanism alleviate related epidemics non-alcoholic fatty liver disease type diabetes
